By M&A — Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher Arrowhead Pharmaceuticals, Inc.
Auto-published by the finit.news Events monitor from M&A; summarized by AI and may contain errors — verify against the primary source. August 4, 2026.